This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Beth M Mammini
Introduction
Beth M Mammini is a notable inventor based in Walnut Creek, California. He has made significant contributions to the field of medical technology, particularly in the area of opto-acoustic thrombolysis. His work focuses on the development of innovative diagnostic methods that enhance the effectiveness of medical treatments.
Latest Patents
Beth M Mammini holds a patent for a groundbreaking invention titled "Bubble diagnostics." This invention is designed to diagnose the presence of a gas bubble and integrate this information into a feedback system for opto-acoustic thrombolysis. The process involves delivering pulsed laser radiation at ultrasonic frequencies through an optical fiber to target thrombus or occluded vessels. The formation of a vapor bubble as a result of laser irradiation is crucial, as it can disrupt the occlusion or generate a pressure wave. Understanding the formation and lifetime of this vapor bubble provides essential data regarding its maximum size, the density of absorbed radiation, and the properties of the absorbing material. This information is vital for adjusting irradiation conditions to optimize treatment outcomes.
Career Highlights
Beth M Mammini is affiliated with the University of California, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve medical procedures and patient outcomes.
Collaborations
He has collaborated with esteemed colleagues such as Steven R Visuri and Luiz B Da Silva, contributing to a rich environment of innovation and research.
Conclusion
Beth M Mammini's contributions to the field of medical technology through his patent on bubble diagnostics exemplify the impact of innovative thinking in healthcare. His work not only enhances diagnostic capabilities but also paves the way for more effective treatments in the future.
